A high frequency of climate-change associated severe weather events have created an increased human-to-human transmission risk for novel diseases.
All articles by Cindy Lampner, MSLIS
Experts examine the reasoning behind a steep rise in tick-borne illnesses, such as Lyme disease, in the United States and discuss the best ways to thwart this serious public health threat.
A higher dose of the flu vaccine provided better protection against respiratory and all-cause hospital admissions.
A new study examined whether isoniazid resistance was associated with variations in treatment outcomes in patients receiving standard first-line pharmacotherapy for TB.
Influenza vaccination during pregnancy decreases infant hospitalizations for all-cause acute lower respiratory tract infection during the first 3 months of life.
People who had been vaccinated with the MeNZB vaccine were less likely to have gonorrhea than people who weren’t vaccinated.
Results from atrial of clindamycin in cellulitis cast doubt on hospital guidelines.
Rapid treatment of sepsis using mandated care bundles improves outcomes.
Epidemiological study finds reassuring outcomes for Brazilian babies born to mothers with symptomatic dengue during pregnancy.
Retrospective study analyzes whether preadmission oral corticosteroids might lower ARDS risk in patients admitted to the ICU.
Recurrent Clostridium difficile infection is associated with a significant economic and mortality burden, but new treatment shows promise.
The adjuvanted H7N1 vaccine was safe and immunogenic after 2 doses in adults age 65 and older, according to a new study.
A World Health Organization expert panel recommended lay health care workers be allowed to conduct HIV testing services using rapid diagnostic tests.
Risk for pneumonia should be considered when weighing the benefits and risks of benzodiazepines in patients with Alzheimer disease.
No difference in warfarin requirements seen in HIV-infected and HIV-uninfected patients with venous thrombosis.
Moderate diet-induced weight loss has important therapeutic cardiometabolic effects in HIV-positive women with obesity.
Phase 1b trial finds tetravalent E coli bioconjugate vaccine candidate in women with recurrent UTI safe and immunogenic.
Intravenous zanamivir is as safe and efficacious as oral oseltamivir in hospitalized patients with severe influenza.
Enhancing contraceptive access may be an important strategy to reduce Zika virus-related microcephaly births.
Bezlotoxumab was particularly effective in patients with risk factors for poor outcome, including older age, immunocompromise, and severe infection.
Trial finds the combination of simeprevir, daclatasvir, and sofosbuvir generally safe and well tolerated in HCV patients with decompensated liver disease.
Metabolic alkalosis did not have any effect on 30-day and 12-month mortality in patients with severe sepsis or septic shock.
In sub-Saharan Africa, a 4-fold increase has been seen in pretreatment HIV drug resistance in children with prenatal exposure to ART.
A 4-antigen vaccine for Staphylococcus aureus disease demonstrates robust functional immune responses durable through month 12.
Combination antiretroviral therapy is associated with an overall reduction in liver fibrosis in HIV-infected patients with and without hepatitis co-infections.
In a randomized controlled trial, researchers found that liposomal lidocaine provided consistent analgesia during infant vaccination.
Literature review and meta-analysis reveal poor treatment outcomes in patients with isoniazid-resistant TB.
Neither getting flu infection nor vaccine during pregnancy is associated with risk of autism in the child.
Annualized rates of hospitalization for parapneumonic empyema fell after introduction of the 13-valent pneumococcal conjugate vaccine.